Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): protocol for a randomised controlled trial.

Lisa Mary RavenChristopher A MuirCassia Kessler IglesiasNicole K BartKavitha MuthiahEugene KotlyarPeter MacdonaldChristopher S HaywardAndrew JabbourJerry R Greenfield

Published in: BMJ open (2023)

ACTRN12622000978763.

Keyphrases

left ventricular
randomized controlled trial
heart failure
type diabetes
adipose tissue
insulin resistance
weight loss